コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 activation of protein kinase A (PKA; eg, by beta-adrenergic stimulation).
2 al fibrosis and attenuated responsiveness to beta-adrenergic stimulation).
3 restore myocyte contractility in response to beta adrenergic stimulation.
4 itoring [Ca(2+)](SR) and Ca(2+) waves during beta-adrenergic stimulation.
5 Surprisingly, BAT was not activated during beta-adrenergic stimulation.
6 to achieve localized temporal regulation of beta-adrenergic stimulation.
7 wo steps of adipose lipolysis in response to beta-adrenergic stimulation.
8 ular arrhythmias in young individuals during beta-adrenergic stimulation.
9 phosphorylation and cardiac function during beta-adrenergic stimulation.
10 duced heart rate in response to work load or beta-adrenergic stimulation.
11 evelopment of cardiac hypertrophy induced by beta-adrenergic stimulation.
12 entials; the firing frequency increased with beta-adrenergic stimulation.
13 en species and induction of autophagy during beta-adrenergic stimulation.
14 output changes and is accompanied in vivo by beta-adrenergic stimulation.
15 he L-type Ca2+ channel Cav1.2 in response to beta-adrenergic stimulation.
16 the systolic Ca2+ transient alone and during beta-adrenergic stimulation.
17 ocardial contractility and relaxation during beta-adrenergic stimulation.
18 inetics observed in living myocardium during beta-adrenergic stimulation.
19 n by sildenafil blunts systolic responses to beta-adrenergic stimulation.
20 dels of I(Ks) in the absence and presence of beta-adrenergic stimulation.
21 ced calcium entry, using I(Ks) blockade with beta-adrenergic stimulation.
22 ilar to that of wild type mouse hearts under beta-adrenergic stimulation.
23 horylated by protein kinase A in response to beta-adrenergic stimulation.
24 ions that may be especially important during beta-adrenergic stimulation.
25 elaxation was significantly decreased during beta-adrenergic stimulation.
26 he hypertrophic and antiapoptotic effects of beta-adrenergic stimulation.
27 butes to increased rate of relaxation during beta-adrenergic stimulation.
28 phorylation in accelerating relaxation after beta-adrenergic stimulation.
29 ase channel (ryanodine receptor, RyR) during beta-adrenergic stimulation.
30 ting brown adipocyte function in response to beta-adrenergic stimulation.
31 nt but modifies the hypertrophic response to beta-adrenergic stimulation.
32 nction by phospholamban is a major target of beta-adrenergic stimulation.
33 ergy metabolism, and an abnormal response to beta-adrenergic stimulation.
34 ute to greater contractility in hearts after beta-adrenergic stimulation.
35 I and is essential to the relaxant effect of beta-adrenergic stimulation.
36 r mediating the maximal cardiac responses to beta-adrenergic stimulation.
37 ipates in NO-mediated negative feedback over beta-adrenergic stimulation.
38 , whereas beta-lumicolchicine did not affect beta-adrenergic stimulation.
39 ased by voluntary exercise and by persistent beta-adrenergic stimulation.
40 ulum through PLB phosphorylation mediated by beta-adrenergic stimulation.
41 (SR) through PLB phosphorylation mediated by beta-adrenergic stimulation.
42 inephrine, but not with selective alpha- and beta-adrenergic stimulation.
43 ted, it was no longer sensitive to volume or beta-adrenergic stimulation.
44 ystolic intracellular calcium in response to beta-adrenergic stimulation.
45 ine but preserved NO activity in response to beta-adrenergic stimulation.
46 markedly blunted the contractile response to beta-adrenergic stimulation.
47 lowed relaxation, and depressed responses to beta-adrenergic stimulation.
48 ude of contraction) but were unresponsive to beta-adrenergic stimulation.
49 e explained by changes in the sensitivity to beta-adrenergic stimulation.
50 ng the contractile responses of the heart to beta-adrenergic stimulation.
51 culum which is phosphorylated in response to beta-adrenergic stimulation.
52 n cardiac contractile parameters and loss of beta-adrenergic stimulation.
53 creased cardiac contractility in response to beta-adrenergic stimulation.
54 ythmias in structurally normal hearts during beta-adrenergic stimulation.
55 contribute to the net stimulatory effect of beta-adrenergic stimulation.
56 refractory for several minutes from further beta-adrenergic stimulation.
57 Ms restores a positive inotropic response to beta-adrenergic stimulation.
58 role in modulating troponin function during beta-adrenergic stimulation.
59 r cTnI (KC-I) or contractile kinetics during beta-adrenergic stimulation.
60 phorylation by protein kinase A (PKA) during beta-adrenergic stimulation.
61 chronotropic but null inotropic responses to beta-adrenergic stimulation.
62 of cTn by phosphorylation of S23/S24 during beta-adrenergic stimulation.
63 ilin-2 and lethal arrhythmias in response to beta-adrenergic stimulation.
64 These effects were reversed by beta-adrenergic stimulation.
65 ance early phase diastolic relaxation during beta-adrenergic stimulation.
66 omoted early-after-depolarisations following beta-adrenergic stimulation.
67 Ca(2+) release in cardiac myocytes evoked by beta-adrenergic stimulation.
68 n adipocyte differentiation and activated by beta-adrenergic stimulation.
69 use of increased intracellular Ca(2+) during beta-adrenergic stimulation.
70 ncy response and the contractile response to beta-adrenergic stimulation.
71 n of spark-mediated J(leak) increases due to beta-adrenergic stimulation.
72 of arrhythmias in human atrial strips during beta-adrenergic stimulation.
73 x sensitized PKA phosphorylation of KCNQ1 to beta-adrenergic stimulation.
74 amatically delayed their decay after a brief beta-adrenergic stimulation.
75 t WT and mutant Kv11.1 channels responded to beta-adrenergic stimulation.
76 nst pro-arrhythmogenic Ca(2+) release during beta-adrenergic stimulation.
77 duction in channel activation in response to beta-adrenergic stimulation.
78 idation and opposes the metabolic effects of beta-adrenergic stimulation.
81 decrease in spark-to-spark delays seen with beta-adrenergic stimulation; (5) inhibiting either PKA o
82 decrease in spark-to-spark delays seen with beta-adrenergic stimulation; (5) inhibiting either PKA o
83 ically paced myocytes, both with and without beta-adrenergic stimulation (70 nM isoproterenol (isopre
84 monary cAMP and AFC were also observed after beta-adrenergic stimulation, a pathway known to promote
86 ity and impaired chronotropic response under beta-adrenergic stimulation, accompanied by the appearan
87 ed a significant increase in the response to beta-adrenergic stimulation after LVAD (developed tensio
88 e PTX treatment increases the sensitivity to beta-adrenergic stimulation alone and that this could ac
90 ined in both the absence and the presence of beta-adrenergic stimulation although the beta-agonist ac
91 calcium channels become phosphorylated after beta-adrenergic stimulation, although this does not lead
92 ve inotropic response of the murine heart to beta-adrenergic stimulation, an effect that is highly de
93 association between ion channel response to beta-adrenergic stimulation and clinical response to bet
94 4F-AG-AMT displayed cardiac-like response to beta-adrenergic stimulation and contractile properties.
95 of contraction are increased in response to beta-adrenergic stimulation and high-frequency electrica
96 and amplitude of cardiac contraction during beta-adrenergic stimulation and increased stimulus frequ
97 such modulation enhances rather than blunts beta-adrenergic stimulation and is accompanied by increa
98 ation of L-type Ca2+ currents in response to beta-adrenergic stimulation and local increases in cAMP.
99 his blunts the local contractile response to beta-adrenergic stimulation and may serve to protect aga
100 and this process is dynamically regulated by beta-adrenergic stimulation and phosphorylation of phosp
103 periments were performed to test the role of beta-adrenergic stimulation and PKA phosphorylation of S
105 e NO/nitrates is independent and additive to beta-adrenergic stimulation and stimulates CGRP release.
106 interactive effect between oil-exposure and beta-adrenergic stimulation and suggests if animals achi
107 n of cGMP in the heart can potently modulate beta-adrenergic stimulation, and alterations in enzyme l
109 fractional shortening and responsiveness to beta-adrenergic stimulation, and it limited development
110 ncement of cardiac function that occurs upon beta-adrenergic stimulation, and mutations in MyBP-C cau
111 pment and relaxation as a result of enhanced beta-adrenergic stimulation, and reduced MyBP-C phosphor
112 y cytokine expression through alpha- but not beta-adrenergic stimulation, and suggest that such alpha
113 We show that Jhdm2a expression is induced by beta-adrenergic stimulation, and that Jhdm2a directly re
114 loss of inotropic reserve, uncovered during beta-adrenergic stimulation, and the presence of cardiac
115 e (Ca(2+) wave latency) was prolonged during beta-adrenergic stimulation, and was highly dependent on
116 tion, and apoptosis in response to sustained beta-adrenergic stimulation; and (3) the beneficial effe
117 rdiac function and the inotropic response to beta-adrenergic stimulation are impaired in sepsis.
118 insufficient to regulate respiration during beta-adrenergic stimulation, arguing against intracrine
119 arts exhibit positive inotropic responses to beta-adrenergic stimulation as a consequence of protein
121 lates action potential duration (APD) during beta-adrenergic stimulation at different heart rates are
122 sights into arrhythmogenic mechanisms during beta-adrenergic stimulation besides triggered activity a
124 uggests responsiveness (increase in rate) to beta-adrenergic stimulation (betaAS), as observed experi
126 ontractility and the contractile response to beta-adrenergic stimulation by a NO-cGMP-mediated decrea
127 ed that the activation of glycolysis through beta-adrenergic stimulation by endogenous catecholamines
128 v11.1 and T421M-Kv11.1 channels responded to beta-adrenergic stimulation by increasing I(Kv11.1).
129 herefore conclude that systemic nonselective beta-adrenergic stimulation by ISO at concentrations tha
131 AMP (cAMP) concentrations, a known effect of beta-adrenergic stimulation, by addition of dibutyryl cA
134 by a Ca-regulated kinase is necessary before beta-adrenergic stimulation can produce additional phosp
135 on of TSC2 gene activity in combination with beta-adrenergic stimulation can reactivate the cell cycl
137 Our results demonstrate that, in response to beta-adrenergic stimulation, cardiomyocyte function and
138 vate alpha 1-receptors while maintaining the beta-adrenergic stimulation, cells were superfused with
140 show a blunted cardiac inotropic response to beta-adrenergic stimulation despite normal cardiac contr
141 fter induction of apoptotic pathway by using beta-adrenergic stimulation, displayed a similar pattern
150 response to IL-1beta via induction of iNOS; beta-adrenergic stimulation enhances the IL-1beta effect
153 ac function under stress; however, sustained beta-adrenergic stimulation has been implicated in patho
154 ein-C (MyBP-C), are phosphorylated following beta-adrenergic stimulation; however, their relative con
155 DAC9 show a hypertrophic response to chronic beta-adrenergic stimulation identical to that of wild-ty
158 creased by approximately 12% within 3 min of beta-adrenergic stimulation in beating cardiac myocytes.
159 amplitude of the Ca2+ transient produced by beta-adrenergic stimulation in cardiac muscle is due to
161 inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricu
162 ort improved force generation in response to beta-adrenergic stimulation in isolated LV (increase in
164 al contraction and the inotropic response to beta-adrenergic stimulation in murine ventricular myocyt
165 tentiates the positive inotropic response to beta-adrenergic stimulation in patients with symptomatic
166 e that activation of the Ca-ATPase following beta-adrenergic stimulation in the heart only occurs abo
167 xtent of contractility and relaxation during beta-adrenergic stimulation in the intact animal remain
168 y was undertaken to test the hypothesis that beta-adrenergic stimulation in the setting of membrane d
169 tein accounted for the ICaL insensitivity to beta-adrenergic stimulation in VEDS cardiomyocytes.
172 tive amplitude-frequency relationship and in beta-adrenergic stimulation, including decreasing and in
179 s show increased TDR compared with LQT1, and beta-adrenergic stimulation increases TDR in both models
181 ll, the results presented here indicate that beta-adrenergic stimulation increases the spark-dependen
182 ted lusitropic response of cardiac muscle to beta-adrenergic stimulation indicate a novel pathogenic
186 mouse ventricular myocytes by examining how beta-adrenergic stimulation influenced sequences of Ca(2
187 mouse ventricular myocytes by examining how beta-adrenergic stimulation influenced sequences of Ca2+
188 important role in sinus acceleration during beta-adrenergic stimulation, interacting synergistically
189 e hypothesis that sinus rate acceleration by beta-adrenergic stimulation involves synergistic interac
193 e increased incidence of Ca(2+) waves during beta-adrenergic stimulation is due to an alteration in t
194 ggest that the increase in arrhythmias after beta-adrenergic stimulation is independent of enhanced E
195 The increase in Ser-845 phosphorylation upon beta-adrenergic stimulation is much more severely impair
199 s the endogenous theta-rhythm and depends on beta-adrenergic stimulation, is only modestly affected i
202 s if animals achieve very large increases in beta-adrenergic stimulation it could play a compensatory
205 d cardiomyocytes exhibited responsiveness to beta-adrenergic stimulation manifest by an increase in s
207 equency response; (4) inotropic responses to beta-adrenergic stimulation mediated via canonical beta1
208 s in myocardial excitability are mediated by beta-adrenergic stimulation of a cAMP-sensitive K(+) cur
210 In summary, the beta-2 receptor mediates beta-adrenergic stimulation of alveolar epithelial sodiu
212 e RyR/FKBP12.6 association, suggesting minor beta-adrenergic stimulation of Ca2+ release through this
214 vention of C-terminal cleavage did not alter beta-adrenergic stimulation of CaV1.2 in the heart.
215 nsus PKA phosphorylation sites in alpha1C in beta-adrenergic stimulation of CaV1.2, and show that pho
217 motif abolishes insulin counterregulation of beta-adrenergic stimulation of cyclic AMP accumulation a
218 of CaV1.2 channels in cardiac myocytes, and beta-adrenergic stimulation of L-type Ca2+ currents in t
219 uation by muscarinic cholinergic agonists of beta-adrenergic stimulation of L-type calcium current an
220 y adults demonstrate reduced, not increased, beta-adrenergic stimulation of metabolic rate because of
223 Furthermore, the ability of PVN to inhibit beta-adrenergic stimulation of the Ca(2+) current was an
226 We aimed to investigate whether simultaneous beta-adrenergic stimulation offsets this balance in youn
228 etion (NRG-1+/-) and examined the effects of beta-adrenergic stimulation on contractility in the pres
229 kedly with advancing age, but the effects of beta-adrenergic stimulation on filling, and its major de
230 l systems, we studied the effects of chronic beta-adrenergic stimulation on the myocardial and system
232 ovel determinants of the inotropic effect of beta-adrenergic stimulation on the ventricular heart mus
233 Ca2+ channel (LCC) phosphorylation, such as beta-adrenergic stimulation or an increased expression o
235 tor of increased contractility observed with beta-adrenergic stimulation or increased pacing because
236 greatly enhanced contraction in response to beta-adrenergic stimulation (percent increase in contrac
238 -dependent protein kinase II (CaMKII) during beta-adrenergic stimulation prevented the decrease in sp
239 -dependent protein kinase II (CaMKII) during beta-adrenergic stimulation prevented the decrease in sp
240 open probability alone or in the presence of beta-adrenergic stimulation produces diastolic Ca releas
244 S1928 displaces the beta2AR from Cav1.2 upon beta-adrenergic stimulation rendering Cav1.2 refractory
245 n of PKA substrates, elicited in response to beta-adrenergic stimulation, require spatially confined
253 roteins in the heart to be phosphorylated by beta-adrenergic stimulation, the functional impact of ph
254 on, demonstrating a defect in the ability of beta-adrenergic stimulation to regulate sarcoplasmic ret
256 ed sensitivity to frequency potentiation and beta-adrenergic stimulation, two major physiological mec
259 epolarisations or abnormal automaticity with beta-adrenergic-stimulation, using the dynamic-clamp tec
260 The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppress
262 pressure development observed in response to beta-adrenergic stimulation was attenuated in TG(S282A)
264 ibitory G-protein (Galpha(i)) suppression of beta-adrenergic stimulation was greater in DHF and rever
265 ulation of Krebs cycle dehydrogenases during beta-adrenergic stimulation was hampered in Mfn2-KO but
268 of LL absorption postnatally, and that while beta-adrenergic stimulation was the sole source of endog
269 tolic pressure and the effects of alpha- and beta-adrenergic stimulation were examined in both models
270 erturbations or intrinsic signaling, such as beta-adrenergic stimulation, which regulate cardiac calc
271 t relevant source of intracellular NO during beta-adrenergic stimulation, while no evidence for a mit
274 Time-averaged [Ca(2+) ]i was increased by beta-adrenergic stimulation with isoprenaline and increa
275 3, and 6 Hz) in basal conditions and during beta-adrenergic stimulation with isoproterenol (2 nmol/L
277 ences measured under control conditions: (1) beta-adrenergic stimulation with isoproterenol (isoprena
278 ences measured under control conditions: (1) beta-adrenergic stimulation with isoproterenol (isoprena
279 not alter the intracellular Ca2+ response to beta-adrenergic stimulation with isoproterenol but atten
281 in cardiac functional reserve in response to beta-adrenergic stimulation without significant alterati
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。